期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma 被引量:28
1
作者 Ming Gao Minghua Ge +26 位作者 Qinghai Ji Ruochuan Cheng hankui lu Haixia Guan Li Gao Zhuming Guo Tao Huang Xiaoming Huang Xiaoming Li Yansong Lin Qinjiang Liu Xin Ni Yi Pan Jianwu Qin Zhongyan Shan Hui Sun Xudong Wang Zhengang Xu Yang Yu Daiwei Zhao Naisong Zhang ShengZhang Ying Zheng Jingqiang Zhu Dapeng Li Xiangqian Zheng 《Cancer Biology & Medicine》 SCIE CAS CSCD 2017年第3期203-211,共9页
The incidence of papillary thyroid carcinoma(PTC)has exponentially increased in recent years.Papillary thyroid microcarcinoma(PTMC)accounts for the majority of the reported cases of PTC.The debates and crucial issues ... The incidence of papillary thyroid carcinoma(PTC)has exponentially increased in recent years.Papillary thyroid microcarcinoma(PTMC)accounts for the majority of the reported cases of PTC.The debates and crucial issues in PTMC management have received researchers'attention.To further improve the clinical management of PTMC in China, 展开更多
关键词 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma
下载PDF
2017 Chinese expert consensus on the clinical application ofserum marker for thyroid cancer 被引量:3
2
作者 Ming Gao Minghua Ge +26 位作者 Qinghai Ji Ruochuan Cheng hankui lu Haixia Guan Wei Cui Li Gao Zairong Gao Lin Guo Zhuming Guo Tao Huang Xiaoming Huang Yansong Lin Qinjiang Liu Xin Ni Jianwu Qin Li Ren Zhongyan Shan Hui Sun Xudong Wang Zhengang Xu Yang Yu Bin Zhang DaiweiZhao Ying Zheng Jingqiang Zhu Xiangqian Zheng 《Cancer Biology & Medicine》 SCIE CAS CSCD 2018年第4期468-477,共10页
In recent years, the clinical incidence of thyroid cancer has been increasing year by year, and its risk assessment and clinical management methods have also been accordingly modified and constantly improved. There ar... In recent years, the clinical incidence of thyroid cancer has been increasing year by year, and its risk assessment and clinical management methods have also been accordingly modified and constantly improved. There are great differences between the clinical diagnostic and therapeutic modes and disease management of thyroid cancer employed by various medical institutions in China, particularly with regard to the clinical application of serum marker of thyroid cancer. To this end, the China Anti-Cancer Association Thyroid Cancer Specialized Committee Chinese Association of Thyroid Oncology organized this compilation of ExpertConsensus on Clinical Application of Serum Marker of Thyroid Cancer to help and impel relevant clinical institutions and professionals to standardize clinical diagnosis, treatment, and long-term management of thyroid cancer, and to properly utilize the serum marker for scientific auxiliary clinical diagnosis and assessment of thyroid cancer before and after operation. 展开更多
关键词 Chinese expert consensus on the clinical application of serum marker for thyroid cancer MTC TG
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部